{"id":135727,"date":"2022-11-07T10:03:05","date_gmt":"2022-11-07T15:03:05","guid":{"rendered":"https:\/\/44.250.171.167\/?p=135727"},"modified":"2022-11-07T10:03:06","modified_gmt":"2022-11-07T15:03:06","slug":"divis-laboratories-q2fy23-19-fall-in-profits","status":"publish","type":"post","link":"https:\/\/alphastreet.com\/india\/divis-laboratories-q2fy23-19-fall-in-profits\/","title":{"rendered":"Divi’s Laboratories Q2FY23; 19% Fall in Profits"},"content":{"rendered":"\n

Divi’s Laboratories Ltd.<\/a>‘s revenues in Q2FY23 fell 7% to \u20b9 1,855 crores. Consolidated Profit came at \u20b9 494 crores showcasing a 19% fall YoY over the corresponding period.<\/p>\n\n\n\n

\"\"<\/a><\/figure><\/div>\n\n\n\n

In this quarter\u2019s\u00a0results<\/a>, the reports suggested that the firm has observed a fall in profits due to a fall in revenue from operations while witnessing a 6% YoY increase in Total Expenses.<\/p>\n","protected":false},"excerpt":{"rendered":"

Divi’s Laboratories Ltd.‘s revenues in Q2FY23 fell 7% to \u20b9 1,855 crores. Consolidated Profit came at \u20b9 494 crores showcasing a 19% fall YoY over the corresponding period. In this quarter\u2019s\u00a0results, the reports suggested that the firm has observed a fall in profits due to a fall in revenue from operations while witnessing a 6% […]<\/p>\n","protected":false},"author":1885,"featured_media":135732,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"jetpack_post_was_ever_published":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":true,"jetpack_social_post_already_shared":true,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[105,392,5747],"tags":[10162],"class_list":["post-135727","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-infographics","category-earnings","category-healthcare-stocks","tag-pharmaceutical"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/alphastreet.com\/india\/wp-content\/uploads\/2022\/11\/Q2FY23-DIVISLAB-1.jpg","jetpack_likes_enabled":false,"jetpack-related-posts":[{"id":154152,"url":"https:\/\/alphastreet.com\/india\/divis-laboratories-ltd-q1fy24-49-fall-in-profits\/","url_meta":{"origin":135727,"position":0},"title":"Divi’s Laboratories Ltd Q1FY24; 49% fall in Profits","author":"Divyansh_Kasana","date":"August 16, 2023","format":false,"excerpt":"Incorporated in 1990, Divis Laboratories Ltd manufactures and exports API's, Intermediates and Nutraceutical ingredients Financial Results: Divi's Laboratories Ltd reported Revenues for Q1FY24 of \u20b91,778.00 Crores down from \u20b92,255.00 Crore year on year, a fall of 21.15%. Total Expenses for Q1FY24 of \u20b91,367.00 Crores down from \u20b91,491.00 Crores year on\u2026","rel":"","context":"In "AlphaGraphs"","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-1149.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-1149.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-1149.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-1149.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-1149.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/08\/image-1149.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":159861,"url":"https:\/\/alphastreet.com\/india\/deepak-nitrite-ltd-q3fy24-3-fall-in-profits\/","url_meta":{"origin":135727,"position":1},"title":"Divi’s Laboratories Ltd Q3FY24; 17% rise in Profits","author":"Divyansh_Kasana","date":"March 14, 2024","format":false,"excerpt":"Incorporated in 1990, Divis Laboratories Ltd manufactures and exports API's, Intermediates and Nutraceutical ingredients Financial Results: Divi's Laboratories Ltd reported Revenues for Q3FY24 of \u20b91,855.00 Crores up from \u20b91,708.00 Crore year on year, a rise of 8.61%. Total Expenses for Q3FY24 of \u20b91,461.00 Crores up from \u20b91,386.00 Crores year on\u2026","rel":"","context":"In "AlphaGraphs"","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/03\/image-156.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/03\/image-156.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/03\/image-156.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/03\/image-156.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/03\/image-156.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/03\/image-156.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":180421,"url":"https:\/\/alphastreet.com\/india\/divis-laboratories-reports-steady-q3-fy26-growth-amid-labour-code-impact\/","url_meta":{"origin":135727,"position":2},"title":"Divi’s Laboratories Reports Steady Q3 FY26 Growth Amid Labour Code Impact","author":"Staff Correspondent","date":"February 11, 2026","format":false,"excerpt":"Divi's Laboratories Limited (NSE: DIVISLAB), a leading Indian API manufacturer, posted consolidated total income of INR 2,692 crores for Q3 FY26 ended December 31, 2025, reflecting a 12% year-over-year increase from INR 2,401 crores. Q3 FY26 Consolidated Performance Profit before tax (PBT) reached INR 780 crores, up from INR 726\u2026","rel":"","context":"In "Analysis"","block_context":{"text":"Analysis","link":"https:\/\/alphastreet.com\/india\/category\/stock-analysis\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2021\/11\/Earnings-Coverage.jpg?resize=525%2C300&ssl=1 1.5x"},"classes":[]},{"id":162397,"url":"https:\/\/alphastreet.com\/india\/divis-laboratories-ltd-q4fy24-68-rise-in-profits\/","url_meta":{"origin":135727,"position":3},"title":"Divi’s Laboratories Ltd Q4FY24; 68% rise in Profits","author":"Divyansh_Kasana","date":"June 20, 2024","format":false,"excerpt":"Incorporated in 1990, Divis Laboratories Ltd manufactures and exports API's, Intermediates and Nutraceutical ingredients Financial Results: Divi's Laboratories Ltd reported Revenues for Q4FY24 of \u20b92,303.00 Crores up from \u20b91,951.00 Crore year on year, a rise of 18.04%. Total Expenses for Q4FY24 of \u20b91,669.00 Crores up from \u20b91,551.00 Crores year on\u2026","rel":"","context":"In "AlphaGraphs"","block_context":{"text":"AlphaGraphs","link":"https:\/\/alphastreet.com\/india\/category\/infographics\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/06\/image-185.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/06\/image-185.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/06\/image-185.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/06\/image-185.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/06\/image-185.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2024\/06\/image-185.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":154677,"url":"https:\/\/alphastreet.com\/india\/divis-laboratories-pioneering-innovation-and-growth-in-the-pharmaceutical-frontier\/","url_meta":{"origin":135727,"position":4},"title":"Divi’s Laboratories: Pioneering Innovation and Growth in the Pharmaceutical Frontier","author":"Divyansh_Kasana","date":"September 20, 2023","format":false,"excerpt":"Stock Data: TickerNSE: DIVISLABSExchangeNSEIndustryPharmaceutical Price Performance: Last 5 Days+0.43 %YTD+12.23 %Last 12 Months+5.91 %As on 20-09-2023 Company Description: Divi's Laboratories is a leading pharmaceutical company headquartered in India, recognized for its excellence in research, development, and manufacturing of Active Pharmaceutical Ingredients (APIs) and custom synthesis solutions. With a commitment to\u2026","rel":"","context":"In "Research Summary"","block_context":{"text":"Research Summary","link":"https:\/\/alphastreet.com\/india\/category\/research-summary\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/09\/f6ceac66-f2a3-45a2-ae80-d4455cad9356-2-3.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/09\/f6ceac66-f2a3-45a2-ae80-d4455cad9356-2-3.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/09\/f6ceac66-f2a3-45a2-ae80-d4455cad9356-2-3.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/09\/f6ceac66-f2a3-45a2-ae80-d4455cad9356-2-3.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/09\/f6ceac66-f2a3-45a2-ae80-d4455cad9356-2-3.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/09\/f6ceac66-f2a3-45a2-ae80-d4455cad9356-2-3.png?resize=1400%2C800&ssl=1 4x"},"classes":[]},{"id":140018,"url":"https:\/\/alphastreet.com\/india\/divis-labs-ltd-nsedivislab-q3-fy23-results-outtotal-income-rises-5-yoy\/","url_meta":{"origin":135727,"position":5},"title":"Divis Labs Ltd.(NSE:DIVISLAB )|Q3 FY23 Results Out|Total Income rises 5% yoy","author":"Divyansh_Kasana","date":"February 3, 2023","format":false,"excerpt":"Divi's Laboratories Limited (NSE: DIVISLAB) is a pharmaceutical company specializing in the manufacture of active pharmaceutical ingredients (APIs) and intermediates. The company operates globally, with facilities in India, the United States, and Europe, and serves customers in over 60 countries. Divi's Laboratories is known for its strong focus on quality\u2026","rel":"","context":"In "Analysis"","block_context":{"text":"Analysis","link":"https:\/\/alphastreet.com\/india\/category\/stock-analysis\/"},"img":{"alt_text":"","src":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/fa084a5e-371a-4ccb-95c8-d5eeac5c1854-1.png?resize=350%2C200&ssl=1","width":350,"height":200,"srcset":"https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/fa084a5e-371a-4ccb-95c8-d5eeac5c1854-1.png?resize=350%2C200&ssl=1 1x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/fa084a5e-371a-4ccb-95c8-d5eeac5c1854-1.png?resize=525%2C300&ssl=1 1.5x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/fa084a5e-371a-4ccb-95c8-d5eeac5c1854-1.png?resize=700%2C400&ssl=1 2x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/fa084a5e-371a-4ccb-95c8-d5eeac5c1854-1.png?resize=1050%2C600&ssl=1 3x, https:\/\/i0.wp.com\/alphastreet.com\/india\/wp-content\/uploads\/2023\/02\/fa084a5e-371a-4ccb-95c8-d5eeac5c1854-1.png?resize=1400%2C800&ssl=1 4x"},"classes":[]}],"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/135727","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/users\/1885"}],"replies":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/comments?post=135727"}],"version-history":[{"count":0,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/posts\/135727\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media\/135732"}],"wp:attachment":[{"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/media?parent=135727"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/categories?post=135727"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/alphastreet.com\/india\/wp-json\/wp\/v2\/tags?post=135727"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}